国产精品99一区二区三_免费中文日韩_国产在线精品一区二区_日本成人手机在线

Hong Kong scientists discover deadly brain cancer mutation route

Source: Xinhua| 2018-12-03 22:09:36|Editor: Li Xia
Video PlayerClose

HONG KONG, Dec. 3 (Xinhua) -- The mutational mechanism of a rare and deadly brain cancer has been uncovered by scientists from the Hong Kong University of Science and Technology, providing new therapeutic lead to the disease.

Starting off at nerve cells around the spine and brain, lower-grade glioma (LGG) is the early form of sGBM -- one of the deadliest brain cancers. While sGBM can be treated with surgery or an oral chemotherapy drug, most of these malign tumors would mutate and return with mortality rate reaching almost 100 percent.

In their latest study made public on Monday, the team led by Wang Jiguang, assistant professor at the university's Division of Life Science and Department of Chemical and Biological Engineering, analyzed and integrated the genomic data of 188 sGBM patients, including newly collected samples from Chinese mainland and South Korean patients.

The study found that about 14 percent of the sampled sGBM patients displayed mutations in this gene.

Taking reference from this discovery, the university's collaborators, Jiang Tao and his team from Beijing Neurosurgical Institute and Beijing Tiantan Hospital, identified a drug molecule named PLB-1001 that can reach the tumors in the brain.

The molecule shows remarkable potency in selectively targeting sGBM tumors and those displaying further gene mutations.

The clinical trial of PLB-1001 on 18 recurrent patients at late cancer stage returned with a partial positive response in two patients.

After being prescribed a daily dosage ranging from 50 to 300 mg at Beijing Tiantan Hospital, the two patients experienced significant tumor shrinkage, with relieved symptoms and little side effects, lasting for more than 12 weeks.

The outcome of this clinical trial is significant in a sense that it furthers the knowledge about sGBM treatment, Wang said, adding that developing computational models on cancer evolution helps predict cancer cells' future behavior and prioritize treatment options.

Wang said more studies on PLB-1001 are needed to see if it can be used in conjunction with other drugs in achieving more persistent results.

The findings were published in scientific journal Cell on Nov. 29.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001376484241
主站蜘蛛池模板: 海南省| 肥乡县| 崇左市| 宜春市| 繁峙县| 鹤岗市| 宜黄县| 洪洞县| 广灵县| 巍山| 吉林省| 克什克腾旗| 禹城市| 安国市| 申扎县| 通榆县| 城口县| 娄烦县| 密山市| 永丰县| 揭西县| 鄂温| 磴口县| 政和县| 吴忠市| 图木舒克市| 汉川市| 万山特区| 武陟县| 定西市| 元朗区| 阳山县| 寻乌县| 徐州市| 同江市| 霍城县| 嘉鱼县| 呼伦贝尔市| 聂拉木县| 英德市| 阳城县|